Trump’s New CDC Chief Reportedly Promoted a Sketchy Anti-Aging Therapy

She also partnered with Coke—to fight obesity.

Highwaystarz-Photography/Getty/iStock

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.

Donald Trump’s appointee to lead the Centers for Disease Control and Prevention apparently practiced a fringe branch of medicine that promises to reverse the effects of natural aging. This little nugget comes courtesy of Forbes contributor Rita Rubin, who dug up the 2011 homepage of Dr. Brenda Fitzgerald’s medical practice. (Fitzgerald practiced for decades as an OB/GYN.) “My goal is to have all my patients, and me, be vigorous and vital for essentially their entire lives,” the FAQ section reads. “I want to be struck by lightning on the golf course at 120…. and I want that for you.”

How did Fitzgerald plan to get her patients to golfing at age 120? Through “bioidentical hormones,” an anti-aging regimen discredited by mainstream doctors. The American Congress of Obstetricians and Gynecologists notes that “evidence is lacking to support superiority claims of compounded bioidentical hormones over conventional menopausal hormone therapy.”

Fitzgerald’s practice claimed that “we can now measure the vitamins, antioxidants, necessary fats, and proteins in your cells with a simple blood test.” But ACOG warns that “despite claims to the contrary, evidence is inadequate to support increased efficacy or safety for individualized hormone therapy regimens based on salivary, serum, or urinary testing.” Harvard Medical School points out that bioidentical hormones haven’t been studied in long-term trials. A gynecology professor quoted in Rubin’s Forbes piece says such anti-aging treatments are “snake oil,” and notes that “If [Fitzgerald] was one of these people who was marketing anti-aging medicine, that’s scary.”

On top of being ineffective, such treatments could be dangerous. Most bioidentical hormone protocols require the use of a compounding pharmacy, which ACOG points out are very loosely regulated—meaning the drugs have “variable purity and potency.” Contaminated drugs from compounding pharmacies have even killed people.

Anti-aging medicine is not recognized as a medical specialty by the American Medical Association, yet Fitzgerald lists it among her credentials. She is a fellow of the American Academy of Anti-Aging Medicine, whose stated mission is to promote “the research of practices and protocols that have the potential to optimize the human aging process.” The CDC did not return a phone call seeking comment, but Fitzgerald’s anti-aging fellowship is touted on her bio page at the Georgia Department of Public Health, where she served as commissioner for seven years—at one point partnering with the Coca-Cola company on an anti-obesity initiative.

In addition, Fitzgerald has run for Congress twice and, with her husband, donated more than $25,000 to the Republican party, according to the New York Times

AN IMPORTANT UPDATE ON MOTHER JONES' FINANCES

We need to start being more upfront about how hard it is keeping a newsroom like Mother Jones afloat these days.

Because it is, and because we're fresh off finishing a fiscal year, on June 30, that came up a bit short of where we needed to be. And this next one simply has to be a year of growth—particularly for donations from online readers to help counter the brutal economics of journalism right now.

Straight up: We need this pitch, what you're reading right now, to start earning significantly more donations than normal. We need people who care enough about Mother Jones’ journalism to be reading a blurb like this to decide to pitch in and support it if you can right now.

Urgent, for sure. But it's not all doom and gloom!

Because over the challenging last year, and thanks to feedback from readers, we've started to see a better way to go about asking you to support our work: Level-headedly communicating the urgency of hitting our fundraising goals, being transparent about our finances, challenges, and opportunities, and explaining how being funded primarily by donations big and small, from ordinary (and extraordinary!) people like you, is the thing that lets us do the type of journalism you look to Mother Jones for—that is so very much needed right now.

And it's really been resonating with folks! Thankfully. Because corporations, powerful people with deep pockets, and market forces will never sustain the type of journalism Mother Jones exists to do. Only people like you will.

There's more about our finances in "News Never Pays," or "It's Not a Crisis. This Is the New Normal," and we'll have details about the year ahead for you soon. But we already know this: The fundraising for our next deadline, $350,000 by the time September 30 rolls around, has to start now, and it has to be stronger than normal so that we don't fall behind and risk coming up short again.

Please consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

—Monika Bauerlein, CEO, and Brian Hiatt, Online Membership Director

payment methods

AN IMPORTANT UPDATE ON MOTHER JONES' FINANCES

We need to start being more upfront about how hard it is keeping a newsroom like Mother Jones afloat these days.

Because it is, and because we're fresh off finishing a fiscal year, on June 30, that came up a bit short of where we needed to be. And this next one simply has to be a year of growth—particularly for donations from online readers to help counter the brutal economics of journalism right now.

Straight up: We need this pitch, what you're reading right now, to start earning significantly more donations than normal. We need people who care enough about Mother Jones’ journalism to be reading a blurb like this to decide to pitch in and support it if you can right now.

Urgent, for sure. But it's not all doom and gloom!

Because over the challenging last year, and thanks to feedback from readers, we've started to see a better way to go about asking you to support our work: Level-headedly communicating the urgency of hitting our fundraising goals, being transparent about our finances, challenges, and opportunities, and explaining how being funded primarily by donations big and small, from ordinary (and extraordinary!) people like you, is the thing that lets us do the type of journalism you look to Mother Jones for—that is so very much needed right now.

And it's really been resonating with folks! Thankfully. Because corporations, powerful people with deep pockets, and market forces will never sustain the type of journalism Mother Jones exists to do. Only people like you will.

There's more about our finances in "News Never Pays," or "It's Not a Crisis. This Is the New Normal," and we'll have details about the year ahead for you soon. But we already know this: The fundraising for our next deadline, $350,000 by the time September 30 rolls around, has to start now, and it has to be stronger than normal so that we don't fall behind and risk coming up short again.

Please consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

—Monika Bauerlein, CEO, and Brian Hiatt, Online Membership Director

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate